Recommended Tests for HIV Diagnosis
The recommended initial HIV screening test is a combination HIV antibody/p24 antigen test, which has sensitivity and specificity greater than 99.5%, followed by confirmatory testing with Western blot or immunofluorescent assay for positive results. 1, 2
HIV Testing Algorithm
Initial Screening
Combination HIV antibody/p24 antigen test (preferred initial screening test)
- Detects both HIV antibodies and p24 antigen
- Allows earlier detection of HIV infection than antibody-only tests
- Sensitivity and specificity >99.5%
- Results available within 1-2 days from commercial laboratories 1
Rapid HIV testing (alternative for immediate results)
- Can use blood or oral fluid specimens
- Results available in 5-40 minutes
- Sensitivity and specificity >99.5%
- Positive results require confirmation with conventional methods 1
Confirmatory Testing
For reactive initial screening tests:
HIV-1/HIV-2 antibody differentiation immunoassay
- Differentiates between HIV-1 and HIV-2 antibodies 2
If differentiation assay is negative or indeterminate:
- Nucleic Acid Amplification Test (NAAT) such as HIV RNA PCR
- Rules out acute HIV infection
- Detects virus directly rather than antibody response 2
Special Testing Considerations
For Infants and Children <18 Months
HIV DNA PCR testing is preferred
- Detects HIV genetic material directly
- Not affected by maternal antibodies
- 93% of infected infants test positive by 14 days of age 2
Recommended testing schedule:
- Initial test by 48 hours of age
- Testing at 14 days (if available)
- Testing at 1-2 months
- Testing at 3-6 months 2
For Recent Exposures
Persons with recent known or possible HIV exposure should be tested using:
- Rapid or laboratory-based Ag/Ab test
- Consider adding HIV NAT (RNA test) for very recent exposures 1
Follow-up testing after exposure:
- Laboratory-based Ag/Ab test AND diagnostic NAT at 4-6 weeks
- Final HIV testing 12 weeks after exposure 1
Additional Laboratory Tests After HIV Diagnosis
Once HIV infection is confirmed, the following tests should be ordered:
CD4 cell count with percentage
- Assesses immune status and disease progression
- Baseline for monitoring treatment response 1
HIV viral load (HIV RNA level)
- Establishes baseline viral activity
- Helps determine need for antiretroviral therapy
- Used to monitor response to therapy 1
HIV genotype testing
- Assesses for transmitted drug resistance
- Guides selection of antiretroviral therapy 1
Additional screening tests
- Complete blood count with differential
- Comprehensive metabolic panel
- Screening for co-infections (hepatitis, tuberculosis, STIs)
- HLA-B*5701 testing before abacavir use
- CCR5 tropism testing if considering maraviroc 1
Recommended Screening Frequency
- All sexually active individuals: At least once in their lifetime 1
- High-risk populations: Every 3-12 months
- Men who have sex with men
- Transgender women
- People who inject drugs
- Persons with multiple sexual partners 1
- Pregnant women: During each pregnancy 2
Common Pitfalls to Avoid
False-negative results during "window period"
False-positive screening results
- Can occur with autoimmune disorders or pregnancy
- Always confirm positive screening tests 1
Relying solely on antibody tests for infants <18 months
- Maternal antibodies persist up to 18 months
- Use virologic tests (DNA PCR) instead 2
Missing acute infections
- Fourth-generation Ag/Ab tests shorten but don't eliminate window period
- Consider HIV RNA testing when acute infection is suspected 3
Delayed linkage to care
- Immediately connect diagnosed individuals to HIV care
- Early treatment improves outcomes and reduces transmission 1